van der Heijde, DésiréeDésiréevan der HeijdeTanaka, YoshiyaYoshiyaTanakaFleischmann, RoyRoyFleischmannKeystone, EdwardEdwardKeystoneKremer, JoelJoelKremerZerbini, CristianoCristianoZerbiniCardiel, Mario HMario HCardielCohen, StanleyStanleyCohenNash, PeterPeterNashSong, Yeong-WookYeong-WookSongTegzová, DanaDanaTegzováWyman, Bradley TBradley TWymanGruben, DavidDavidGrubenBenda, BirgittaBirgittaBendaWallenstein, GeneGeneWallensteinKrishnaswami, SriramSriramKrishnaswamiZwillich, Samuel HSamuel HZwillichBradley, John DJohn DBradleyConnell, Carol ACarol AConnellPING-NING HSU2023-09-282023-09-282013-0300043591https://pubmed.ncbi.nlm.nih.gov/23348607/https://scholars.lib.ntu.edu.tw/handle/123456789/635857The purpose of this 24-month phase III study was to examine structural preservation with tofacitinib in patients with rheumatoid arthritis (RA) with an inadequate response to methotrexate (MTX). Data from a planned 12-month interim analysis are reported.enjournal article10.1002/art.37816233486072-s2.0-84874402383https://api.elsevier.com/content/abstract/scopus_id/84874402383